Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.
ARVO 2025: Perfuse Therapeutics announces positive results from phase 1/2a trial of PER-001, an intravitreal implant for glaucoma
New Opportunities in Topical Glaucoma Management
Oral zervimesine reduced GA lesion growth in phase 2 study from Cognition Therapeutics
You and Eye: Vision training research in eSports - with Tiffany Tsoi, OD, FAAO
Bausch + Lomb's LuxLife IOL receives CE Mark approval in Europe
Anthem Blue Cross Blue Shield approves coverage for amblyopia treatment from Luminopia